Vincent Klaren

Scientist Biophysics and Process Analytics

Amsterdam, North Holland, Netherlands

About

- Involvement in projects ranging from early R&D to pre-clinical and phase I trials - Adapt quickly to work in different disease areas - Development of biomarker assays - Creative and resourceful personality with organizational skills • keywords: clinical science; biomarkers; predictive markers; infectious diseases, antibody therapy, vaccines; assay development & technology solutions; antivirals; protein engineering; biomarker identification; mode of action studies; high throughput screening; automation; clinical immunology; microscopy; high content imaging; big data visualization; big data analytics; R programming; team leader.

Experience

  • The Janssen Pharmaceutical Companies of Johnson & Johnson (8 yrs 10 mos)
    • Scientist biophysics and process analytics
      Apr 2021 - Oct 2023 · 2 yrs 7 mos

    • Scientist Preventive Analytics, Bioinformatics and Predictive Biomarkers
      Feb 2018 - Mar 2022 · 4 yrs 2 mos

      Exploration and design of high throughput and proof of concept assays for disease markers. Supervision of internal and external lab explorations on assays and technologies, supporting outsourcing decisions and CRO management. • Biomarker discovery • Data analysis and visualization using R

    • Scientist Predictive Markers
      Jan 2015 - Jan 2018 · 3 yrs 1 mo

      Managing the development of diagnostic assays for Alzheimers Disease • Assay development • Biomarker discovery • Automation • Miniaturization • Data analysis and visualization using R

  • Crucell (8 yrs)
    • Scientist Innovation & Discovery
      May 2013 - Dec 2014 · 1 yr 8 mos

      Antibody Discovery and Characterization (Infectious Diseases) & Development of bio-assays • Lead a team of technicians • Characterization of antivirals/monoclonal antibodies (lead molecules) • Mechanism of action studies, cell-based infection assays, biochemical/enzymatic assays. • (Bio-) assay development for non-clinical characterization of lead molecules • Setup bio-marker assays for clinical trials • Contributed data to successful IND filings and up to phase II clinical trials

    • Associate Research Scientist Innovation & Discovery
      Jan 2007 - Apr 2013 · 6 yrs 4 mos

      Discovery antiviral molecules to fight infectious diseases • Screening antibodies, peptides, and small molecules for virus neutralization activity • Mechanism of action studies in cell-models. • Live cell imaging and tracking of virus (laser scanning confocal imaging) • Characterization of broadly neutralizing antibodies against human pathogens such as Influenza and HCV • Development of cell- and imaging-based assays • Design and test virus production platforms (Polio and Influenza)

  • Laboratory Head at ChromaGenics B.V.
    Jan 2004 - Jan 2007 · 3 yrs 1 mo

    • Head of cell culture division of 7 technicians • Management and design experiments • Transfection and clone generation to establish eukaryotic transgene expression platforms • Test novel genetic repression blocker elements for transgene expression

  • Research Technician, Netherlands Ophthalmic Research Institute at KNAW - Koninklijke Nederlandse Akademie van Wetenschappen
    Mar 1991 - Mar 1995 · 4 yrs 1 mo

    Research of autoimmune ocular pathology • Analysis of intra-ocular cytokine responses in rats after induced uveitis • T cell receptor analysis of synovial T cells of HLA-B27 positive RA patients